Menopausal symptoms. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Intervention group: The fennel capsule group in this study will receive 30 mg Fennelin soft capsules (standardized to 21-27 mg of Antole) twice a day for 8 weeks orally. Fennelin soft
Sponsors
Guilan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Willingness to participate in the study and sign a written informed consent form At least ability to read and write Women with normal menopause and age over 40 years Lapse of at least12 months since the last menstruation, according to the Stages of Reproductive Aging Workshop+ 10 (STRAW+10) criteria Menopause less than 5 years (according to the person's statement) Having a score of 9 and above on the Menopause Rating Scale (MRS)
Exclusion criteria
Exclusion criteria: History of respiratory disease (asthma and allergy), kidney disease, coagulation disease, hemophilia, inflammatory disease, liver disease and gallstones, cancer, epilepsy/seizures, and uterine diseases (such as fibroids, adenomyosis, and endometriosis). Allergy reaction to celery and fennel Taking immunosuppressive drugs, anticoagulants (such as warfarin and heparin), neuropsychiatric drugs, antioxidant supplements, herbal drugs, and hormone therapy Smoking and alcohol consumption Stressful factors (such as the death of a first-degree relative in the last 6 months and job loss)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menopausal symptoms score. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: Menopause Rating Scale (MRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParvaneh Rezasoltani
Guilan University of Medical Sciences
Outcome results
None listed